Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-21-018628

EVP, GM Cell Therapy acquired 50,825 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
De Groot Eleanor EVP, GM Cell Therapy 2021-03-04 Grant or award +50,825 257,238 D
Derivatives
De Groot Eleanor EVP, GM Cell Therapy 2021-03-04 Grant or award · Employee Stock Option (right to buy) +381,188 381,188 D
Loading xslF345X03/doc4.xml…